Search

1 Aug 2023: On occasion and where necessary, auditors. On occasion, the above types of sharing may involve the transfer of your personal information outside of the European Economic Area (e.g.

23 Feb 2023: patients”. Tags:Image: Test tubes. Stay in touch with the latest updates from Cambridge Enterprise.

22 Feb 2023: The business, which spun out of the University of Cambridge, is focused on capturing hidden economic insights that exist in online data, giving clients a comprehensive overview of what is changing

1 Aug 2023: Transferring your information outside the United Kingdom or European Economic Area (EEA).

22 Feb 2023: The SEIS was announced in the 2012 budget as part of the government’s strategy for stimulating economic growth.

22 Feb 2023: We are very pleased to see the significant economic and societal impact that our portfolio companies are having. ... Geraldine Rodgers. Geraldine Rodgers, Head of Seed Funds at Cambridge Enterprise, said “We are very pleased to see the significant

22 Feb 2023: Consequently, it is often affected by toxic compounds. Demonstrating that a new drug candidate is free from liver toxicity is a key test in the development process, and it is a ... test that most drug candidates fail.

23 Feb 2023: This was the second year for the Enterprise Fund, which was established following the announcement of the SEIS programme in the government’s 2012 budget in order to stimulate economic growth.

22 Feb 2023: The test will enable patients to seek treatment before complications arise and without the inconvenience, cost and delays associated with current testing methods. ... Kalium Health aims to launch its first test as an approved medical device within four

22 Feb 2023: The next step is to then test the vaccine in pre-clinical trials—in other words, give the vaccine to mice to check that it is safe to use.

22 Feb 2023: The objective is to build a portfolio of new products to complement and enrich PredictImmune’s prognostic test pipeline in the coming years. ... This will significantly improve clinical outcomes and enhance patient welfare. The team at PredictImmune

10 Oct 2023: A recent report by London Economics said that the economic impact of the University of Cambridge was almost £30 billion a year, or four times that of the English Premier League. ... With a brief to make a measurable economic impact for the whole UK, the

10 Oct 2023: Alongside Oxford University Innovation, who are spearheading the consortium, LSE Innovation (London School of Economics and Political Science’s commercialisation team) will co-lead the project’s training and knowledge dissemination.

23 Feb 2023: genetic test that benefits cancer patients by pinpointing the best drug for treating their tumour; and Inkling, which is developing graphene-enhanced windblade coatings that are resistant to rain erosion, thereby

23 Feb 2023: The company is based upon the research of Professor Chris Abell and Professor Wilhelm Huck (pictured, with Chief Executive Frank Craig), and is developing droplets that serve as ‘miniature test tubes’. ... The X-MAN models, or ‘patients in a test

22 Feb 2023: The UK, EU and Canadian patents expand PredictImmune’s existing patent portfolio and further protect the organisation’s current IP in the development of prognostic tests across a broad range of ... The R&D phase of the test has been completed and the

22 Feb 2023: This was the second year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth.

23 Feb 2023: The SEIS was announced in the 2012 budget as part of the government’s strategy for stimulating economic growth.

22 Feb 2023: Tests with a home assistant platform showed that sentence recognition rate in noisy conditions jumped from 22 percent to 94 percent.

22 Sep 2023: Earlier this year, a new report by leading consultants London Economics showed that the University adds nearly £30 billion to the economy every year and supports more than 86,000 jobs

21 Nov 2023: Its recommendations, if successfully implemented, should enhance the economic and societal impact of university-inspired innovation, which continues to solve some of the world’s greatest challenges. ... sector around its aim to save lives and increase

23 Feb 2023: Riverlane is building a simulation engine for microscopic systems to replace expensive laboratory tests with computer simulation.

22 Feb 2023: It does not require installation. The Bolt allows scientists and researchers in drug discovery and plant managers or quality control staff in pharmaceutical manufacturing facilities to perform the necessary tests

23 Feb 2023: of miniaturised tests in tiny picodroplets. ... Among other things, the technology allows tests on individual cells as well as whole “libraries” of cells.

23 Feb 2023: The scale of the potential economic impact of the EU’s proposed restriction can be seen in data submitted by the industry to the ECHA’s stakeholder workshop.

22 Feb 2023: These next-generation iPS cell products will help to improve the efficiency and economics of drug development, and enable the underlying mechanisms of disease to be elucidated in a manner that ... Dr Marcus Yeo, CEO, DefiniGEN, commented: “These

5 Oct 2023: Ceres Agri-Tech has an established track record for the translation of world leading science that can concurrently drive economic and environmental productivity within the agricultural sector. ... A key priority for UKRI is to strengthen clusters and

22 Feb 2023: The funds will be used to test the novel p300/CBP inhibitor in late stage, treatment-resistant prostate cancer (up to Phase IIb).

14 Sep 2023: Industry relationships are essential to our ambitions to create economic and social impact from academic research.

22 Feb 2023: This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth.

22 Feb 2023: This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth.

22 Feb 2023: valuable proposition for any academic or company that wants to see early stage ground breaking therapeutic technology progress to the clinic for patient benefit and economic return. ... for patient benefit and economic return.”.

22 Feb 2023: The objective of the research collaboration with Prof Wade-Martins is to test Mission’s potent and selective USP30 inhibitors in a range of disease models—induced Pluripotent Stem Cells ... There is no objective test, or biomarker, for Parkinson’s

19 May 2023: The USIT guide will enable the investment community to work more closely with our universities to create high impact businesses that can drive UK economic growth.

22 Feb 2023: As with IBD, patients with SLE can present with a variable disease course, and it is this variability that makes it an ideal choice for the development of a prognostic test

20 Apr 2023: Preventing avoidable conditions and treating disease efficiently and effectively, we will see radical improvements not just in health, but health economics.